60,689 Shares in Humana Inc. (NYSE:HUM) Acquired by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Humana Inc. (NYSE:HUM - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 60,689 shares of the insurance provider's stock, valued at approximately $15,397,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.05% of Humana as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Transcend Capital Advisors LLC increased its position in shares of Humana by 399.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock valued at $924,000 after buying an additional 2,914 shares in the last quarter. Retirement Systems of Alabama increased its position in shares of Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after buying an additional 192,801 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after buying an additional 65,735 shares in the last quarter. denkapparat Operations GmbH purchased a new position in shares of Humana in the fourth quarter valued at $323,000. Finally, South Dakota Investment Council increased its position in shares of Humana by 39.9% in the fourth quarter. South Dakota Investment Council now owns 153,317 shares of the insurance provider's stock valued at $38,898,000 after buying an additional 43,719 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently commented on the company. Raymond James upgraded Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective for the company in a research report on Thursday, May 1st. JPMorgan Chase & Co. dropped their price objective on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research report on Tuesday, February 18th. Morgan Stanley dropped their price objective on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 12th. Oppenheimer lifted their price objective on Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. Finally, Robert W. Baird lifted their price objective on Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Sixteen analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $284.48.

Humana Trading Up 1.0%

Shares of NYSE HUM traded up $2.20 during midday trading on Tuesday, hitting $233.59. The stock had a trading volume of 347,849 shares, compared to its average volume of 1,773,494. The company has a market capitalization of $28.19 billion, a price-to-earnings ratio of 23.48, a PEG ratio of 2.05 and a beta of 0.49. Humana Inc. has a 1-year low of $212.45 and a 1-year high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The company has a fifty day moving average price of $256.32 and a 200 day moving average price of $266.21.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, topping the consensus estimate of $10.07 by $1.51. The firm had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. Humana's revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the previous year, the company posted $7.23 EPS. On average, analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.52%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is presently 25.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.